NMPA

Explore the landscape of NMPA in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on NMPA to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

AstraZeneca to Invest USD 2 Billion in Summit Therapeutics – Clinical Collaboration Anchored on Ivonescimab and Claudin 18.2 ADC Sone‑Ve
CompanyDeals

AstraZeneca to Invest USD 2 Billion in Summit Therapeutics – Clinical Collaboration Anchored on Ivonescimab and Claudin 18.2 ADC Sone‑Ve

Summit Therapeutics Inc. (NASDAQ: SMMT) announced an agreement with AstraZeneca plc (NYSE: AZN) under which AstraZeneca will make an equity investment of USD 2 billion in convertible preferred shares in…

AstraZeneca Submits FDA NDA for Orpathys–Tagrisso Combination – Targeting MET‑Altered NSCLC After EGFR TKI Failure

AstraZeneca Submits FDA NDA for Orpathys–Tagrisso Combination – Targeting MET‑Altered NSCLC After EGFR TKI Failure

Ascletis Reports Positive 28‑Day Proof‑of‑Concept Results for ASC50 – Oral IL‑17A Small Molecule Delivers 48.9% Placebo‑Adjusted PASI Reduction in Mild‑to‑Moderate Plaque Psoriasis

Ascletis Reports Positive 28‑Day Proof‑of‑Concept Results for ASC50 – Oral IL‑17A Small Molecule Delivers 48.9% Placebo‑Adjusted PASI Reduction in Mild‑to‑Moderate Plaque Psoriasis

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Policy / Regulatory

China Releases Third List of Pediatric Drugs to Guide Development and Filings

Policy / Regulatory

NMPA Releases 72nd Batch of Reference Drugs for GQCE

Legal / IPPolicy / Regulatory

National Health Commission’s Anti-Corruption Drive Impacts China’s Pharmaceutical Sector

Policy / Regulatory

NMPA Seeks Public Input on Strengthening Supervision of Medical Device Contract Manufacturing

Medical DevicePolicy / Regulatory

NMPA Updates List of Medical Devices Exempt from Clinical Evaluation in China

Legal / IPPolicy / Regulatory

National Health Commission Launches One-Year Anti-Corruption Campaign in Pharmaceutical Sector

DrugPolicy / Regulatory

NMPA Releases 70th Batch of Reference Drugs for Generic Quality Consistency Evaluation

CompanyDrug

Shanghai Fosun Pharmaceutical Submits Tenapanor Approval Application to China’s NMPA

Show More